Optimization of pH-sensitive peptide nanoconstructs for use in targeting the mildly acidic tumor microenvironment

Investigators: Jennica Zaro, Ph.D. Peter Conti, M.D., Ph.D.
Innovation: a method to recognize the minute differences in pH levels near tumor cells
Clinical significance: enabling more powerful cancer-killing drugs to be used without side effects

Multiplexed Polysilicon Nanoribbon Sensors for Therapeutic Monitoring and Detection of Brain Cancer

Investigators: Chongwu Zhou; Mark Thompson; Thomas Chen

Scintillating Nanoparticles for Radiosensitization of Cancer Cells

Investigators: Stephen Bradforth; Colin Hill; Jay Nadeau; Jonathon Ha; Eric Chang

Targeted Nanoparticle Therapy for Ewing’s Sarcoma

Investigators: Timothy Triche; Richard Roberts

Targeting the Mildly Acidic Tumor Microenvironment using pH-sensitive Recombinant Peptide Nanoconstructs

Investigators: Jennica Zaro; Peter Conti